CA2567331A1 - Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity - Google Patents
Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity Download PDFInfo
- Publication number
- CA2567331A1 CA2567331A1 CA002567331A CA2567331A CA2567331A1 CA 2567331 A1 CA2567331 A1 CA 2567331A1 CA 002567331 A CA002567331 A CA 002567331A CA 2567331 A CA2567331 A CA 2567331A CA 2567331 A1 CA2567331 A1 CA 2567331A1
- Authority
- CA
- Canada
- Prior art keywords
- comprised
- coil
- fibers
- metal wire
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12154—Coils or wires having stretch limiting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/128—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Abstract
Vaso-occlusive coils comprising fibers. The vaso-occlusive coil (12) can be a helical coil or a double helix made of biocompatible metal wire whereas the fibers (14, 16, 18, 28) are enlaced between at least a winding of the coil (12) and are made of polymeric materials like copolymers of glycolic/lactic acid. The fibers (14, 16, 18, 28) or the coil (12) can be coated with a bioactive material. The device (10) can comprise a stretch-resistant member and can be radio-opaque.
Claims (217)
1. A vaso-occlusive device for occluding blood flow in a patient comprising a) a coil sized for insertion to a point of use in a vascular network of the patient, where the coil is comprised of a first surface area; and b) a plurality of enlaced fibers where the enlaced fibers are comprised of a second surface area where the second surface area is at least 0.1 times the surface area of the first surface area.
2. The device of claim 1, wherein the coil is a helical coil.
3. The device of claim 1, wherein the fibers are enlaced through the coil.
4. The device of claim 1, wherein the coil is comprised of metal wire.
5. The device of claim 4, wherein the metal wire is a biocompatible metal wire.
6. The device of claim 4, wherein the metal wire is at least 5 mm in length.
7. The device of claim 4, wherein the metal wire is radio-opaque.
8. The device of claim 4, wherein the metal wire is comprised of a metal chosen from platinum, palladium, rhodium, rhenium, iridium, gold, silver, tungsten and tantalum or an alloy of these metals.
9. The device of claim 8, wherein the metal wire is comprised of a platinum iridium alloy.
10. The device of claim 8, wherein the metal wire is comprised of a platinum tungsten alloy.
11. The device of claim 4, wherein the metal wire is comprised of a super-elastic metal.
12. The device of claim 11, wherein the super-elastic metal is nitinol.
13. The device of claim 4, wherein the metal wire has a diameter of about 0.025 mm to about 0.09 mm.
14. The device of claim 4, wherein the metal wire has a diameter of about 0.04 mm to about 0.06 mm.
15. The device of claim 1, wherein the coil is comprised of a primary helix which is itself wound into a secondary shape.
16. The device of claim 15, wherein the secondary shape is a complicated three dimensional structure.
17. The device of claim 15, wherein the secondary shape is another helix.
18. The device of claim 17, wherein the secondary shape is a double helix.
19. The device of claim 15, wherein the primary helix has a diameter of about 0.1 millimeters to about 0.8 millimeters.
20. The device of claim 15, wherein the primary helix has a diameter of about 0.28 millimeters.
21. The device of claim 15, wherein the primary helix has a diameter of about 0.24 millimeters.
22. The device of claim 15, wherein the primary helix has about 2 to about 50 windings per millimeter.
23. The device of claim 15, wherein the primary helix is comprised of a pitch that provides for free space between adjacent coils.
24. The device of claim 23, wherein up to about 60% of the length of secondary shape is comprised of the free space.
25. The device of claim 23, wherein about 0% to about 25% of the length of secondary shape is comprised of the free space.
26. The device of claim 25, wherein the free space is small enough to permit the adjacent coils to grip the fibers.
27. The device of claim 1, wherein a majority of fibers each enlace a single winding of the helical coil.
28. The device of claim 1, wherein a majority of fibers each enlace two or more windings of the helical coil.
29. The device of claim 1, wherein the fibers are comprised of a bioactive material.
30. The device of claim 1, wherein the fibers are comprised of a non-bioactive material.
31. The device of claim 1, wherein the fibers are comprised of a copolymer of glycolic acid and lactic acid.
32. The device of claim 1, further comprising a bioactive coating.
33. The device of claim 32, wherein the bioactive coating is a lubricious hydrophilic coating.
34. The device of claim 32, wherein the bioactive coating is a hydrophobic coating.
35. The device of claim 32, wherein the bioactive coating is applied to the fiber.
36. The device of claim 32, wherein the bioactive coating is a copolymer.
37. The device of claim 36, wherein the copolymer is comprised of lactic acid and glycolic acid.
38. The device of claim 1, wherein the fibers are comprised of non-biodegradable polymer.
39. The device of claim 38, wherein the non-biodegradable polymer is chosen from a polyethylene, a polyacrylic, a polypropylene, a polyvinylchloride, a polyamide, a polyurethane, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyvinylacetate, a cellulose acetate, a polystyrene, a polytetrafluoroethylene, a polyester, silk or cotton.
40. The device of claim 38, wherein the non-biodegradable polymer is nylon.
41. The device of claim 38, wherein the non-biodegradable polymer is polyethylene terephthalate.
42. The device of claim 1, wherein the fibers are comprised of biodegradable polymer.
43. The device of claim 42, wherein the biodegradable polymer is chosen from polyglycolic acid, polycaprolactone, polyhydroxybutyrate valerate, polyorthoester, polylactic acid, poly (p-dioxanone), poly (valetolactone), poly (tartronic acid), poly (.beta.-malonic acid), poly (propylene fumarate), a tyrosine based polycarbonate, and a copolymer of polyethylene oxide and polybutylene terephthalate.
44. The device of claim 31, wherein the ratio of glycolic acid to lactic acid is 99:1.
45. The device of claim 31, wherein the ratio of glycolic acid to lactic acid is 1:99.
46. The device of claim 31, wherein the ratio of glycolic acid to lactic acid is 95:5.
47. The device of claim 31, wherein the ratio of glycolic acid to lactic acid is 5:95.
48 The device of claim 31, wherein the ratio of glycolic acid to lactic acid is 50:50.
49. The device of claim 31, wherein the ratio of glycolic acid to lactic acid is 90:10.
50. The device of claim 32, wherein the coating material is chosen from a growth factor, a gene, an oligonucleotide, a peptide, a marine biopolymer, a mono-saccahride, a di-saccahride, a poly-saccahride, collagen and combinations of any of the aforementioned.
51. The device of claim 32, wherein the coating is applied to the coil.
52. The device of claim 35, wherein the coating is applied to the fiber as a single layer.
53. The device of claim 43, wherein the bioactive coating is applied to the coil as a single layer.
54. The device of claim 32, wherein the bioactive coating is dispersed throughout the fiber.
55. The device of claim 32, wherein the coating promotes cell attachment and is thrombogenic.
56 The device of claim 55, wherein the coating material is chosen from collagen, fibrinogen, vitronectin, vascular endothelial growth factor, a peptide comprising the sequence arginine-glycine-aspartic acid (RGD).
57. A method of treating an aneurysm in a patient comprising introducing a vaso-occlusive device into the patient thereby treating the aneurysm, wherein the vaso-occlusive device comprises a) a coil sized for insertion to a point of use in a vascular network of the patient, where the coil is comprised of a first surface area; and b) a plurality of enlaced fibers where the enlaced fibers are comprised of a second surface area where the second surface area is at least 0.1 times the surface area of the first surface area.
58. The method of claim 57, wherein the coil has a complicated 3 dimensional structure.
59. The method of claim 57, wherein the coil is a helix.
60. The method of claim 57, wherein the vaso-occlusive device is introduced using a catheter.
61. The method of claim 57, wherein the vaso-occlusive device is introduced through an entry site in the vasculature.
62. The method of claim 61, wherein the entry site is in the femoral artery.
63. A method of making a vaso-occlusive device comprising the steps of a) obtaining a helically coiled wire core having a fiber gripping spacing between adjacent windings when not under tension;
b) extending the wire core into an extended condition;
c) enlacing between adjacent windings of said core a plurality of fibers, thereby increasing the surface area of the coil by at least a factor of 0.1;
and d) relaxing the coil thereby causing the adjacent windings of the coil to grip the enlaced fibers.
b) extending the wire core into an extended condition;
c) enlacing between adjacent windings of said core a plurality of fibers, thereby increasing the surface area of the coil by at least a factor of 0.1;
and d) relaxing the coil thereby causing the adjacent windings of the coil to grip the enlaced fibers.
64. The method of claim 63, wherein the fibers are comprised of a copolymer of polyglycolic acid and lactic acid.
65. The method of claim 63, wherein the enlacing is around a single winding.
66. The method of claim 63, wherein the enlacing is through a single winding.
67. The method of claim 63, wherein the enlacing is through multiple windings.
68. The method of claim 63, wherein the enlacing forms an "S" configuration.
69. A vaso-occlusive device for occluding blood flow in a patient comprising a) a coil sized for insertion to a point of use in a vascular network of the patient; and b) a plurality of enlaced fibers where the enlaced fibers are comprised of a copolymer of lactic acid and glycolic acid.
70. The device of claim 69, wherein the coil is a helical coil.
71. The device of claim 69, wherein the fibers are enlaced through the coil.
72. The device of claim 69, wherein the coil is comprised of metal wire.
73. The device of claim 72, wherein the metal wire is a biocompatible metal wire.
74. The device of claim 72, wherein the metal wire is at least 5 mm in length.
75. The device of claim 72, wherein the metal wire is radio-opaque.
76. The device of claim 72 wherein the metal wire is comprised of a metal chosen from platinum, palladium, rhodium, rhenium, iridium, gold, silver, tungsten and tantalum or an alloy of these metals.
77. The device of claim 76, wherein the metal wire is comprised of a platinum iridium alloy.
78. The device of claim 76, wherein the metal wire is comprised of a platinum tungsten alloy.
79. The device of claim 72, wherein the metal wire is comprised of a super-elastic metal.
80. The device of claim 79, wherein the super-elastic metal is nitinol.
81. The device of claim 72, wherein the metal wire has a diameter of about 0.025 mm to about 0.09 mm.
82. The device of claim 72, wherein the metal wire has a diameter of about 0.04 mm to about 0.06 mm.
83. The device of claim 69, wherein the coil is comprised of a primary helix which is itself wound into a secondary shape.
84. The device of claim 83, wherein the secondary shape is a complicated three dimensional structure.
85. The device of claim 83, wherein the secondary shape is another helix.
86. The device of claim 85, wherein the secondary shape is a double helix.
87. The device of claim 83, wherein the primary helix has a diameter of about 0.1 millimeters to about 0.8 millimeters.
88. The device of claim 83, wherein the primary helix has a diameter of about 0.28 millimeters.
89. The device of claim 83, wherein the primary helix has a.diameter of about 0.24 millimeters.
90. The device of claim 83, wherein the primary helix has about 2 to about 50 windings per millimeter.
91. The device of claim 83, wherein the primary helix is comprised of a pitch that provides for free space between adjacent coils.
92. The device of claim 91, wherein up to about 60% of the length of secondary shape is comprised of the free space.
93. The device of claim 91 wherein about 0% to about 25% of the length of secondary shape is comprised of the free space.
94. The device of claim 93, wherein the free space is small enough to permit the adjacent coils to grip the fibers.
95. The device of claim 69, wherein a majority of fibers each enlace a single winding of the helical coil.
96. The device of claim 69, wherein a majority of fibers each enlace two or more windings of the helical coil.
97. The device of claim 69, wherein the fibers are comprised of a bioactive material.
98. The device of claim 69, wherein the fibers are comprised of a non-bioactive material.
99. The device of claim 69, wherein the fibers are comprised of a copolymer of glycolic acid and lactic acid.
100. The device of claim 69, further comprising a bioactive coating.
101. The device of claim 100, wherein the bioactive coating is a lubricious hydrophilic coating.
102. The device of claim 100, wherein the bioactive coating is a hydrophobic coating.
103 The device of claim 100, wherein the bioactive coating is a copolymer.
104. The device of claim 103, wherein the copolymer is comprised of lactic acid and glycolic acid.
105. The device of claim 69, wherein the fibers are comprised of non-biodegradable polymer.
106. The device of claim 105, wherein the non-biodegradable polymer is chosen from a polyethylene, a polyacrylic, a polypropylene, a polyvinylchloride, a polyamide, a polyurethane, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyvinylacetate, a cellulose acetate, a polystyrene, a polytetrafluoroethylene, a polyester, silk or cotton.
107. The device of claim 105, wherein the non-biodegradable polymer is nylon.
108. The device of claim 105, wherein the non-biodegradable polymer is polyethylene terephthalate.
109. The device of claim 69, wherein the fibers are comprised of biodegradable polymer.
110. The device of claim 109, wherein the biodegradable polymer is chosen from polyglycolic acid, polycaprolactone, polyhydroxybutyrate valerate, polyorthoester, polylactic acid, poly (p-dioxanone), poly (valetolactone), poly (tartronic acid), poly (.beta.-malonic acid), poly (propylene fumarate), a tyrosine based polycarbonate, and a copolymer of polyethylene oxide and polybutylene terephthalate.
111. The device of claim 99, wherein the ratio of glycolic acid to lactic acid is 99:1.
112. The device of claim 99, wherein the ratio of glycolic acid to lactic acid is 1:99.
113. The device of claim 99, wherein the ratio of glycolic acid to lactic acid is 95:5.
114. The device of claim 99, wherein the ratio of glycolic acid to lactic acid is 5:95.
115. The device of claim 99, wherein the ratio of glycolic acid to lactic acid is 50:50.
116. The device of claim 99, wherein the ratio of glycolic acid to lactic acid is 90:10.
117. The device of claim 100, wherein the coating is chosen from a growth factor, a gene, an oligonucleotide, a peptide, a marine biopolymer, a mono-saccahride, a di-saccahride, a poly-saccahride, collagen and combinations of any of the aforementioned.
118. The device of claim 100, wherein the coating is applied to the coil.
119. The device of claim 100, wherein the coating is applied to the fibers as a single layer.
120. The device of claim 118, wherein the bioactive coating is applied to the coil as a single layer.
121. The device of claim 100, wherein the bioactive coating is dispersed throughout the fiber.
122. The device of claim 100, wherein the coating promotes cell attachment and is thrombogenic.
123. The device of claim 122, wherein the coating material is chosen from collagen, fibrinogen, vitronectin, vascular endothelial growth factor, a peptide comprising the sequence arginine-glycine-aspartic acid (RGD).
124. The device of claim 100, wherein the bioactive coating is applied to the fiber.
125. A method of treating an aneurysm in a patient comprising introducing a vaso-occlusive device into the patient thereby treating the aneurysm, wherein the vaso-occlusive device comprises a) a coil sized for insertion to a point of use in a vascular network of the patient, where the coil is comprised of a first surface area; and b) a plurality of enlaced fibers where the enlaced fibers are comprised of a copolymer of lactic acid and glycolic acid.
126. The method of claim 125, wherein the coil has a complicated 3 dimensional structure.
127. The method of claim 125, wherein the coil is a helix.
128. The method of claim 125, wherein the vaso-occlusive device is introduced using a catheter.
129. The method of claim 125, wherein the vaso-occlusive device is introduced through an entry site in the vasculature.
130. The method of claim 129, wherein the entry site is in the femoral artery.
131. A method of making a vaso-occlusive device comprising the steps of a) obtaining a helically coiled wire core having a fiber gripping spacing between adjacent windings when not under tension;
b) extending the wire core into an extended condition;
c) enlacing between adjacent windings of said core a plurality of fibers comprised of a copolymer comprised of lactic acid and glycolic acid; and d) relaxing the coil thereby causing the adjacent windings of the coil to grip the enlaced fibers.
b) extending the wire core into an extended condition;
c) enlacing between adjacent windings of said core a plurality of fibers comprised of a copolymer comprised of lactic acid and glycolic acid; and d) relaxing the coil thereby causing the adjacent windings of the coil to grip the enlaced fibers.
132. The method of claim 131, wherein the enlacing is around a single winding.
133. The method of claim 131, wherein the enlacing is through a single winding.
134. The method of claim 131, wherein the enlacing is through multiple windings.
135. The method of claim 131, wherein the enlacing forms an "S" configuration.
136. A vaso-occlusive device for occluding blood flow in a patient comprising a) a coil, comprising a lumen and a first and a second end, and sized for insertion to a point of use in a vascular network of the patient;
b) a stretch resistant member fixedly attached to at least one end of the coil; and c) a plurality of enlaced fibers where each of the enlaced fibers is enlaced around the stretch resistant member at least two times.
b) a stretch resistant member fixedly attached to at least one end of the coil; and c) a plurality of enlaced fibers where each of the enlaced fibers is enlaced around the stretch resistant member at least two times.
137. The device of 136, wherein the stretch resistant member axially traverses the lumen of the coil.
138. The device of 136, wherein the stretch resistant member is fixedly attached to both the first and second ends of the coil.
139. The device of 136, wherein the plurality of fibers are not tied in a knot.
140. The device of claim 136, wherein the stretch resistant member is comprised of a metal wire.
141. The device of claim 140, wherein the metal wire is radio-opaque.
142. The device of claim 140, wherein the metal wire is comprised of a metal chosen from platinum, palladium, rhodium, rhenium, iridium, gold, silver, tungsten and tantalum or an alloy of these metals.
143. The device of claim 140, wherein the metal wire is comprised of a platinum iridium alloy.
144. The device of claim 140, wherein the metal wire is comprised of a platinum tungsten alloy.
145. The device of claim 140, wherein the metal wire is comprised of a super-elastic metal.
146. The device of claim 145, wherein the super-elastic metal is nitinol.
147. The device of claim 136, wherein the stretch resistant member is comprised of a polymer.
148. The device of claim 147, wherein the polymer is non-biodegradable.
149. The device of claim 147, wherein the polymer is biodegradable.
150. The device of claim 136, wherein the stretch resistant member is further comprised of a bioactive coating.
151. The device of claim 150, wherein the coating is chosen from a growth factor, a gene, an oligonucleotide, a peptide, a marine biopolymer, a mono-saccahride, a di-saccahride, a poly-saccahride, collagen and combinations of any of the aforementioned.
152. The device of claim 150, wherein the coating is a polymer.
153. The device of claim 136, wherein the coil is a helical coil.
154. The device of claim 136, wherein the fibers are enlaced through the coil.
155. The device of claim 136, wherein the coil is comprised of metal wire.
156. The device of claim 155, wherein the metal wire is a biocompatible metal wire.
157. The device of claim 155, wherein the metal wire is at least 5 mm in length.
158. The device of claim 155, wherein the metal wire is radio-opaque.
159. The device of claim 155, wherein the metal wire is comprised of a metal chosen from platinum, palladium, rhodium, rhenium, iridium, gold, silver, tungsten and tantalum or an alloy of these metals.
160. The device of claim 155, wherein the metal wire is comprised of a platinum iridium alloy.
161. The device of claim 155, wherein the metal wire is comprised of a platinum tungsten alloy.
162. The device of claim 155, wherein the metal wire is comprised of a super-elastic metal.
163. The device of claim 162, wherein the super-elastic metal is nitinol.
164. The device of claim 155, wherein the metal wire has a diameter of about 0.025 mm to about 0.09 mm.
165. The device of claim 155, wherein the metal wire has a diameter of about 0.04 mm to about 0.06 mm.
166. The device of claim 136, wherein the coil is comprised of a primary helix which is itself wound into a secondary shape.
167. The device of claim 166, wherein the secondary shape is a complicated three dimensional structure.
168. The device of claim 166, wherein the secondary shape is another helix.
169. The device of claim 166, wherein the secondary shape is a double helix.
170. The device of claim 166, wherein the primary helix has a diameter of about 0.1 millimeters to about 0.8 millimeters.
171. The device of claim 166, wherein the primary helix has a diameter of about 0.28 millimeters.
172. The device of claim 166, wherein the primary helix has a diameter of about 0.24 millimeters.
173. The device of claim 166, wherein the primary helix has about 2 to about 50 windings per millimeter.
174. The device of claim 166, wherein the primary helix is comprised of a pitch that provides for free space between adjacent coils.
175. The device of claim 174, wherein up to about 60% of the length of secondary shape is comprised of the free space.
176. The device of claim 174, wherein about 0% to about 25% of the length of secondary shape is comprised of the free space.
177. The device of claim 174, wherein the free space is small enough to permit the adjacent coils to grip the fibers.
178. The device of claim 136, wherein the fibers are comprised of a bioactive material.
179. The device of claim 136, wherein the fibers are comprised of a non-bioactive material.
180. The device of claim 136, wherein the fibers are comprised of a copolymer of glycolic acid and lactic acid.
181. The device of claim 136, further comprising a bioactive coating.
182. The device of claim 181, wherein the bioactive coating is a lubricious hydrophilic coating.
183. The device of claim 181, wherein the bioactive coating is a hydrophobic coating.
184. The device of claim 181, wherein the bioactive coating is applied to the fiber.
185. The device of claim 181, wherein the bioactive coating is a copolymer.
186. The device of claim 185, wherein the copolymer is comprised of lactic acid and glycolic acid.
187. The device of claim 136, wherein the fibers are comprised of non-biodegradable polymer.
188. The device of claim 187, wherein the non-biodegradable polymer is chosen from a polyethylene, a polyacrylic, a polypropylene, a polyvinylchloride, a polyamide, a polyurethane, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyvinylacetate, a cellulose acetate, a polystyrene, a polytetrafluoroethylene, a polyester, silk or cotton.
189. The device of claim 187, wherein the non-biodegradable polymer is nylon.
190. The device of claim 187, wherein the non-biodegradable polymer is polyethylene terephthalate.
191. The device of claim 136, wherein the fibers are comprised of biodegradable polymer.
192. The device of claim 191, wherein the biodegradable polymer is chosen from polyglycolic acid, polycaprolactone, polyhydroxybutyrate valerate, polyorthoester, polylactic acid, poly (p-dioxanone), poly (valetolactone), poly (tartronic acid), poly (.beta.-malonic acid), poly (propylene fumarate), a tyrosine based polycarbonate, and a copolymer of polyethylene oxide and polybutylene terephthalate.
193. The device of claim 186, wherein the ratio of glycolic acid to lactic acid is 99:1.
194. The device of claim 186, wherein the ratio of glycolic acid to lactic acid is 1:99.
195. The device of claim 186, wherein the ratio of glycolic acid to lactic acid is 95:5.
196. The device of claim 186, wherein the ratio of glycolic acid to lactic acid is 5:95.
197. The device of claim 186, wherein the ratio of glycolic acid to lactic acid is 50:50.
198. The device of claim 186, wherein the ratio of glycolic acid to lactic acid is 90:10.
199. The device of claim 181, wherein the coating material is chosen from, a growth factor, a gene, an oligonucleotide, a peptide, a marine biopolymer, a mono-saccahride, a di-saccahride, a poly-saccahride, collagen and combinations of any of the aforementioned.
200. The device of claim 181, wherein the coating is applied to the coil and the stretch resistant member.
201. The device of claim 181, wherein the coating is applied to the fiber as a single layer.
202. The device of claim 200, wherein the bioactive coating is applied to the coil and the stretch resistant member as a single layer.
203. The device of claim 181, wherein the bioactive coating is dispersed throughout the fiber.
204. The device of claim 181, wherein the coating promotes cell attachment and is thrombogenic.
205. The device of claim 181, wherein the coating material is chosen from collagen, fibrinogen, vitronectin, vascular endothelial growth factor, a peptide comprising the sequence arginine-glycine-aspartic acid (RGD).
206. A method of treating an aneurysm in a patient comprising introducing a vaso-occlusive device into the patient thereby treating the aneurysm, wherein the vaso-occlusive device comprises a) a coil sized for insertion to a point of use in a vascular network of the patient, where the coil is comprised of a first surface area;
b) a stretch resistant member fixedly attached to at least one end of the coil; and c) a plurality of enlaced fibers where each of the enlaced fibers is enlaced around the stretch resistant member at least two times.
b) a stretch resistant member fixedly attached to at least one end of the coil; and c) a plurality of enlaced fibers where each of the enlaced fibers is enlaced around the stretch resistant member at least two times.
207. The method of claim 206, wherein the coil has a complicated 3 dimensional structure.
208. The method of claim 206, wherein the coil is a helix.
209. The method of claim 206, wherein the vaso-occlusive device is introduced using a catheter.
210. The method of claim 206, wherein the vaso-occlusive device is introduced through an entry site in the vasculature.
211. The method of claim 206, wherein the entry site is in the femoral artery.
212. A method of making a vaso-occlusive device comprising the steps of a) obtaining a helically coiled wire core comprising a lumen, a first and second end and a fiber gripping spacing between adjacent windings when not under tension;
b) extending the wire core into an extended condition;
c) inserting a stretch resistant member into the lumen of the helically coiled wire and fixedly attaching the stretch resistant member to at least one end of the helically coiled wire d) enlacing a plurality of fibers around the stretch resistant member at least two times; and e) relaxing the coil thereby causing the adjacent windings of the coil to grip the enlaced fibers.
b) extending the wire core into an extended condition;
c) inserting a stretch resistant member into the lumen of the helically coiled wire and fixedly attaching the stretch resistant member to at least one end of the helically coiled wire d) enlacing a plurality of fibers around the stretch resistant member at least two times; and e) relaxing the coil thereby causing the adjacent windings of the coil to grip the enlaced fibers.
213. The method of claim 212, wherein stretch resistant member is fixedly attached to the first and second end of the helically coiled wire.
214. The method of claim 212, wherein the enlacing is through multiple windings.
215. The method of claim 212, wherein the enlacing forms an "S" configuration.
216. The method of claim 63, wherein the enlacing is around multiple windings.
217. The method of claim 131, wherein the enlacing is around multiple windings.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57371004P | 2004-05-21 | 2004-05-21 | |
US60/573,710 | 2004-05-21 | ||
PCT/US2005/018087 WO2005113035A2 (en) | 2004-05-21 | 2005-05-23 | Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2567331A1 true CA2567331A1 (en) | 2005-12-01 |
CA2567331C CA2567331C (en) | 2012-08-14 |
Family
ID=34978919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2567331A Expired - Fee Related CA2567331C (en) | 2004-05-21 | 2005-05-23 | Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity |
Country Status (8)
Country | Link |
---|---|
US (2) | US7896899B2 (en) |
EP (2) | EP1761178B1 (en) |
JP (2) | JP4723584B2 (en) |
AT (1) | ATE490736T1 (en) |
CA (1) | CA2567331C (en) |
DE (1) | DE602005025215D1 (en) |
ES (2) | ES2357243T3 (en) |
WO (1) | WO2005113035A2 (en) |
Families Citing this family (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070093889A1 (en) * | 1999-01-27 | 2007-04-26 | Wu Benjamin M | Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy |
US6280457B1 (en) * | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
US8048104B2 (en) | 2000-10-30 | 2011-11-01 | Dendron Gmbh | Device for the implantation of occlusion spirals |
WO2003002243A2 (en) | 2001-06-27 | 2003-01-09 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
JP4351405B2 (en) * | 2001-08-29 | 2009-10-28 | インターナショナル・ビジネス・マシーンズ・コーポレーション | Transcoding system and annotation management device |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
JP2004261234A (en) * | 2003-02-20 | 2004-09-24 | Kaneka Medix Corp | Internal indwelling device for forming embolus |
DE102004003265A1 (en) | 2004-01-21 | 2005-08-11 | Dendron Gmbh | Device for the implantation of electrically isolated occlusion coils |
DE602005025215D1 (en) * | 2004-05-21 | 2011-01-20 | Micro Therapeutics Inc | METAL COILS EMBOSSED BY ORGANIC OR BIODEGRADABLE OR SYNTHETIC POLYMERS OR FIBERS FOR THE EMBOLIZATION OF A BODY HEIGHT |
WO2006032291A1 (en) | 2004-09-22 | 2006-03-30 | Dendron Gmbh | Micro-spiral implantation device |
WO2006032289A1 (en) | 2004-09-22 | 2006-03-30 | Dendron Gmbh | Medical implant |
US8535345B2 (en) * | 2004-10-07 | 2013-09-17 | DePuy Synthes Products, LLC | Vasoocclusive coil with biplex windings to improve mechanical properties |
DE102005019782A1 (en) * | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Device for implantation of occlusion coils with internal securing means |
US20070142859A1 (en) * | 2005-12-19 | 2007-06-21 | Boston Scientific Scimed, Inc. | Embolic coils |
US8152839B2 (en) * | 2005-12-19 | 2012-04-10 | Boston Scientific Scimed, Inc. | Embolic coils |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070239194A1 (en) * | 2006-04-05 | 2007-10-11 | Boston Scientific Scimed, Inc. | Vaso-occlusive devices having expandable fibers |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
JP5230602B2 (en) | 2006-04-17 | 2013-07-10 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for mechanically positioning an endovascular implant |
WO2008017028A2 (en) | 2006-08-02 | 2008-02-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
ES2368125T3 (en) | 2006-09-15 | 2011-11-14 | Boston Scientific Scimed, Inc. | BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS. |
JP2010503485A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Medical device and method for manufacturing the same |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
JP2010503489A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
CA2663762A1 (en) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
EP2277563B1 (en) | 2006-12-28 | 2014-06-25 | Boston Scientific Limited | Bioerodible endoprostheses and method of making the same |
CA2679112C (en) * | 2007-03-05 | 2015-08-11 | Boston Scientific Limited | Deploying embolic coils |
AU2008226694B8 (en) | 2007-03-13 | 2013-06-20 | Covidien Lp | An implant including a coil and a stretch-resistant member |
KR20100015521A (en) * | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant, a mandrel, and a method of forming an implant |
CN101917911B (en) | 2007-07-27 | 2013-06-19 | 微排放器公司 | Detachable coil incorporating stretch resistance |
DE102007038446A1 (en) * | 2007-08-14 | 2009-02-19 | pfm Produkte für die Medizin AG | Embolisiereinrichtung |
US8052745B2 (en) * | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US20100256600A1 (en) * | 2009-04-04 | 2010-10-07 | Ferrera David A | Neurovascular otw pta balloon catheter and delivery system |
US20100022951A1 (en) * | 2008-05-19 | 2010-01-28 | Luce, Forward, Hamilton 7 Scripps, Llp | Detachable hub/luer device and processes |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US8926680B2 (en) * | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US9220522B2 (en) * | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US9198687B2 (en) * | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US20100174309A1 (en) * | 2008-05-19 | 2010-07-08 | Mindframe, Inc. | Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter |
US8066757B2 (en) * | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US8034075B2 (en) | 2007-11-09 | 2011-10-11 | Micrus Endovascular Corporation | Tethered coil for treatment of body lumens |
EP2231030B1 (en) | 2007-12-21 | 2019-02-27 | MicroVention, Inc. | System and method for locating detachment zone of a detachable implant |
WO2009089297A2 (en) * | 2008-01-07 | 2009-07-16 | Intersect Partners, Llc | Novel enhanced ptna rapid exchange type of catheter system |
JP5457373B2 (en) * | 2008-02-22 | 2014-04-02 | コヴィディエン リミテッド パートナーシップ | Device for blood flow recovery |
WO2009126935A2 (en) * | 2008-04-11 | 2009-10-15 | Mindframe, Inc. | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
WO2009132045A2 (en) * | 2008-04-21 | 2009-10-29 | Nfocus Neuromedical, Inc. | Braid-ball embolic devices and delivery systems |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
EP2285901B1 (en) | 2008-05-06 | 2020-07-22 | CJ CheilJedang Corporation | Biodegradable polyester blends |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP2301486B1 (en) * | 2008-06-27 | 2014-12-24 | Kabushiki Kaisha Kyoto Iryo Sekkei | Vascular stent |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US20100030319A1 (en) * | 2008-07-31 | 2010-02-04 | Boston Scientific Scimed, Inc. | Coils for vascular implants or other uses |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
KR20110043799A (en) * | 2009-10-16 | 2011-04-28 | 강호창 | Micro-coil assembly |
US9814562B2 (en) | 2009-11-09 | 2017-11-14 | Covidien Lp | Interference-relief type delivery detachment systems |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
WO2011119573A1 (en) | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8353952B2 (en) * | 2010-04-07 | 2013-01-15 | Medtronic Vascular, Inc. | Stent with therapeutic substance |
US8945171B2 (en) | 2011-09-29 | 2015-02-03 | Covidien Lp | Delivery system for implantable devices |
US8795313B2 (en) | 2011-09-29 | 2014-08-05 | Covidien Lp | Device detachment systems with indicators |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
KR101315443B1 (en) | 2011-12-02 | 2013-10-07 | 강호창 | Micro-coil assembly |
US10342548B2 (en) | 2012-01-13 | 2019-07-09 | W. L. Gore & Associates, Inc. | Occlusion devices and methods of their manufacture and use |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
US9326774B2 (en) | 2012-08-03 | 2016-05-03 | Covidien Lp | Device for implantation of medical devices |
CN109054254B (en) | 2012-08-17 | 2021-02-02 | Cj第一制糖株式会社 | Bio-based rubber modifiers for polymer blends |
US9119948B2 (en) | 2013-02-20 | 2015-09-01 | Covidien Lp | Occlusive implants for hollow anatomical structures, delivery systems, and related methods |
WO2014165023A1 (en) * | 2013-03-12 | 2014-10-09 | Carnegie Mellon University | Coated vaso-occclusive device for treatment of aneurysms |
US9763667B2 (en) * | 2013-03-14 | 2017-09-19 | Cook Medical Technologies Llc | Embolization coil with barbed fiber |
US10660645B2 (en) | 2013-03-15 | 2020-05-26 | Embo Medical Limited | Embolization systems |
US10675039B2 (en) | 2013-03-15 | 2020-06-09 | Embo Medical Limited | Embolisation systems |
KR102445703B1 (en) | 2013-03-15 | 2022-09-20 | 엠보 메디칼 리미티드 | Embolisation systems |
CN110169802B (en) | 2013-03-15 | 2022-07-08 | 柯惠有限合伙公司 | Delivery and detachment mechanism for vascular implants |
EP3004225A1 (en) | 2013-05-30 | 2016-04-13 | Metabolix, Inc. | Recyclate blends |
FR3008304B1 (en) * | 2013-07-15 | 2016-04-01 | Balt Extrusion | ENDOPROTHESIS FOR THE TREATMENT IN PARTICULAR AN ANEURYSM |
CN105899150B (en) | 2013-07-31 | 2018-07-27 | Neuvt 有限公司 | Method and apparatus for Endovascular Embolization |
US10010328B2 (en) | 2013-07-31 | 2018-07-03 | NeuVT Limited | Endovascular occlusion device with hemodynamically enhanced sealing and anchoring |
US9877729B2 (en) | 2013-12-20 | 2018-01-30 | Microvention, Inc. | Catheter system |
WO2015149029A1 (en) | 2014-03-27 | 2015-10-01 | Metabolix, Inc. | Highly filled polymer systems |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
US9808256B2 (en) | 2014-08-08 | 2017-11-07 | Covidien Lp | Electrolytic detachment elements for implant delivery systems |
US9814466B2 (en) | 2014-08-08 | 2017-11-14 | Covidien Lp | Electrolytic and mechanical detachment for implant delivery systems |
WO2016044188A1 (en) * | 2014-09-15 | 2016-03-24 | Jones Donald K | Intralumenal occlusion devices having improved properties |
US10736730B2 (en) | 2015-01-20 | 2020-08-11 | Neurogami Medical, Inc. | Vascular implant |
US10857012B2 (en) | 2015-01-20 | 2020-12-08 | Neurogami Medical, Inc. | Vascular implant |
US11484319B2 (en) | 2015-01-20 | 2022-11-01 | Neurogami Medical, Inc. | Delivery system for micrograft for treating intracranial aneurysms |
WO2016118420A1 (en) | 2015-01-20 | 2016-07-28 | Neurogami Medical, Inc. | Micrograft for the treatment of intracranial aneurysms and method for use |
US10925611B2 (en) | 2015-01-20 | 2021-02-23 | Neurogami Medical, Inc. | Packaging for surgical implant |
US20180028190A1 (en) * | 2015-03-03 | 2018-02-01 | Kaneka Medix Corporation | Vascular embolization device and production method therefor |
DE202015102060U1 (en) * | 2015-04-24 | 2016-07-27 | Pfm Medical Ag | A medical implant for occluding a defect opening, vessel, organ passage, or other opening in a human or animal body |
US9717503B2 (en) | 2015-05-11 | 2017-08-01 | Covidien Lp | Electrolytic detachment for implant delivery systems |
KR20180137604A (en) | 2016-02-10 | 2018-12-27 | 마이크로벤션, 인코포레이티드 | Devices for vascular occlusion |
US20190076231A1 (en) | 2016-03-10 | 2019-03-14 | Keystone Heart Ltd. | Intra-Aortic Device |
US10828037B2 (en) | 2016-06-27 | 2020-11-10 | Covidien Lp | Electrolytic detachment with fluid electrical connection |
US10828039B2 (en) | 2016-06-27 | 2020-11-10 | Covidien Lp | Electrolytic detachment for implantable devices |
US11051822B2 (en) | 2016-06-28 | 2021-07-06 | Covidien Lp | Implant detachment with thermal activation |
US11191927B2 (en) | 2017-07-31 | 2021-12-07 | Boston Scientific Scimed, Inc. | Dilator with engagement region |
WO2019035884A1 (en) | 2017-08-15 | 2019-02-21 | Boston Scientific Scimed, Inc. | Occlusive medical device system |
US10874402B2 (en) | 2017-10-10 | 2020-12-29 | Boston Scientific Scimed, Inc. | Detachable RF energized occlusive device |
WO2022082213A1 (en) | 2017-10-16 | 2022-04-21 | Retriever Medical, Inc. | Clot removal methods and devices with multiple independently controllable elements |
US20220104839A1 (en) | 2017-10-16 | 2022-04-07 | Retriever Medical, Inc. | Clot Removal Methods and Devices with Multiple Independently Controllable Elements |
US10258357B1 (en) | 2017-10-16 | 2019-04-16 | Michael Bruce Horowitz | Catheter based retrieval device with proximal body having axial freedom of movement |
US11284902B2 (en) | 2018-02-01 | 2022-03-29 | Boston Scientific Scimed, Inc. | Method of making a vascular occlusion device |
CN111670021B (en) | 2018-02-01 | 2023-08-04 | 波士顿科学国际有限公司 | Medical device release system |
WO2020211943A1 (en) * | 2019-04-18 | 2020-10-22 | Clearstream Technologies Limited | Embolization devices and methods of manufacturing the same |
US11672946B2 (en) | 2019-09-24 | 2023-06-13 | Boston Scientific Scimed, Inc. | Protection and actuation mechanism for controlled release of implantable embolic devices |
CN116370007A (en) * | 2019-12-24 | 2023-07-04 | 上海微创心脉医疗科技(集团)股份有限公司 | Plugging device and system |
WO2021233553A1 (en) * | 2020-05-22 | 2021-11-25 | Clearstream Technologies Limited | Embolisation devices and methods of manufacturing the same |
US20220313267A1 (en) * | 2021-03-31 | 2022-10-06 | DePuy Synthes Products, Inc. | Bio-absorbable coiled fiber |
CN114081570B (en) * | 2021-12-08 | 2024-03-08 | 杭州拓脉医疗科技有限公司 | Spring ring for embolizing aneurysm and blood vessel |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3174851A (en) | 1961-12-01 | 1965-03-23 | William J Buehler | Nickel-base alloys |
US4238194A (en) * | 1966-10-04 | 1980-12-09 | General Electric Company | Nuclei analysis of solid substances |
US3834394A (en) * | 1969-11-21 | 1974-09-10 | R Sessions | Occlusion device and method and apparatus for inserting the same |
US3753700A (en) * | 1970-07-02 | 1973-08-21 | Raychem Corp | Heat recoverable alloy |
US4346712A (en) * | 1979-04-06 | 1982-08-31 | Kuraray Company, Ltd. | Releasable balloon catheter |
US4545367A (en) * | 1982-07-16 | 1985-10-08 | Cordis Corporation | Detachable balloon catheter and method of use |
CA1256638A (en) * | 1984-07-06 | 1989-06-27 | Motoaki Tanaka | Polymer and its production |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
JP2714454B2 (en) * | 1988-11-07 | 1998-02-16 | 三井東圧化学株式会社 | Method for producing bioabsorbable polyester |
US5122136A (en) * | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5354295A (en) * | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
USRE41029E1 (en) * | 1990-03-13 | 2009-12-01 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US6083220A (en) * | 1990-03-13 | 2000-07-04 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5304194A (en) * | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5226911A (en) * | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5256146A (en) * | 1991-10-11 | 1993-10-26 | W. D. Ensminger | Vascular catheterization system with catheter anchoring feature |
US5443478A (en) * | 1992-09-02 | 1995-08-22 | Board Of Regents, The University Of Texas System | Multi-element intravascular occlusion device |
US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5382260A (en) * | 1992-10-30 | 1995-01-17 | Interventional Therapeutics Corp. | Embolization device and apparatus including an introducer cartridge and method for delivering the same |
US5423849A (en) * | 1993-01-15 | 1995-06-13 | Target Therapeutics, Inc. | Vasoocclusion device containing radiopaque fibers |
US6123007A (en) * | 1993-05-19 | 2000-09-26 | Metal Storm Limited | Barrel assembly |
US5423829A (en) * | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
US5624449A (en) * | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
US5549624A (en) * | 1994-06-24 | 1996-08-27 | Target Therapeutics, Inc. | Fibered vasooclusion coils |
US6001092A (en) * | 1994-06-24 | 1999-12-14 | Target Therapeutics, Inc. | Complex coils having fibered centers |
US5485496A (en) * | 1994-09-22 | 1996-01-16 | Cornell Research Foundation, Inc. | Gamma irradiation sterilizing of biomaterial medical devices or products, with improved degradation and mechanical properties |
IL116561A0 (en) * | 1994-12-30 | 1996-03-31 | Target Therapeutics Inc | Severable joint for detachable devices placed within the body |
US5911731A (en) * | 1995-04-20 | 1999-06-15 | Target Therapeutics, Inc. | Anatomically shaped vasoocclusive devices |
US5645558A (en) * | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US6143007A (en) * | 1995-04-28 | 2000-11-07 | Target Therapeutics, Inc. | Method for making an occlusive device |
US5624461A (en) * | 1995-06-06 | 1997-04-29 | Target Therapeutics, Inc. | Three dimensional in-filling vaso-occlusive coils |
US5582619A (en) * | 1995-06-30 | 1996-12-10 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils |
US6013084A (en) * | 1995-06-30 | 2000-01-11 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
US5853418A (en) * | 1995-06-30 | 1998-12-29 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
DE69630898T2 (en) * | 1995-06-30 | 2004-08-26 | Boston Scientific Ltd., Saint Michael | Expansion-resistant vaso-occlusive spiral |
US5847963A (en) * | 1995-10-19 | 1998-12-08 | Gaiski; Stephen N. | Method for monitoring the effect of adjustments of paint application equipment |
AU690862B2 (en) * | 1995-12-04 | 1998-04-30 | Target Therapeutics, Inc. | Fibered micro vaso-occlusive devices |
US5658308A (en) | 1995-12-04 | 1997-08-19 | Target Therapeutics, Inc. | Bioactive occlusion coil |
US5797126A (en) * | 1996-02-16 | 1998-08-18 | Helbling; Edward | Automatic theater ticket concierge |
US5792154A (en) * | 1996-04-10 | 1998-08-11 | Target Therapeutics, Inc. | Soft-ended fibered micro vaso-occlusive devices |
DE19703482A1 (en) * | 1997-01-31 | 1998-08-06 | Ernst Peter Prof Dr M Strecker | Stent |
US5891192A (en) * | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
US6766219B1 (en) * | 1997-05-29 | 2004-07-20 | Gary Marcel Hasey | Apparatus for controlling and monitoring of dispensing of oral medications |
US5984929A (en) * | 1997-08-29 | 1999-11-16 | Target Therapeutics, Inc. | Fast detaching electronically isolated implant |
US6146373A (en) * | 1997-10-17 | 2000-11-14 | Micro Therapeutics, Inc. | Catheter system and method for injection of a liquid embolic composition and a solidification agent |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
WO1999044538A1 (en) * | 1998-01-27 | 1999-09-10 | The Regents Of The University Of California | Biodegradable polymer/protein based coils for intralumenal implants |
US7070607B2 (en) * | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
US5935145A (en) * | 1998-02-13 | 1999-08-10 | Target Therapeutics, Inc. | Vaso-occlusive device with attached polymeric materials |
US5941888A (en) * | 1998-02-18 | 1999-08-24 | Target Therapeutics, Inc. | Vaso-occlusive member assembly with multiple detaching points |
US6013089A (en) * | 1998-04-17 | 2000-01-11 | Goldberg; Barry A. | Tongue cleaner |
US5980550A (en) * | 1998-06-18 | 1999-11-09 | Target Therapeutics, Inc. | Water-soluble coating for bioactive vasoocclusive devices |
US20020087184A1 (en) * | 1998-06-18 | 2002-07-04 | Eder Joseph C. | Water-soluble coating for bioactive devices |
EP1148895B1 (en) * | 1999-02-05 | 2004-11-17 | The Regents of the University of California | Thermo-reversible polymer for intralumenal implant |
US6221066B1 (en) * | 1999-03-09 | 2001-04-24 | Micrus Corporation | Shape memory segmented detachable coil |
US6280457B1 (en) * | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
US8048104B2 (en) * | 2000-10-30 | 2011-11-01 | Dendron Gmbh | Device for the implantation of occlusion spirals |
DE10010840A1 (en) * | 1999-10-30 | 2001-09-20 | Dendron Gmbh | Device for implanting occlusion coils uses coils electrolytically corrodable at several points at intervals so variable sized lengths can be separated by electrolysis |
US6635069B1 (en) * | 2000-10-18 | 2003-10-21 | Scimed Life Systems, Inc. | Non-overlapping spherical three-dimensional coil |
DE10118017B4 (en) * | 2001-04-10 | 2017-04-13 | Dendron Gmbh | Occlusion coil and device for implantation of occlusion coils |
JP2005500121A (en) * | 2001-08-27 | 2005-01-06 | デンドロン・ゲー・エム・ベー・ハー | Occlusion means detention device |
DE60102157T2 (en) * | 2001-09-24 | 2004-07-29 | Evolium S.A.S. | Method for the synchronization of nodes of a terrestrial network provided with GNSS receivers |
DE10155191A1 (en) * | 2001-11-12 | 2003-05-22 | Dendron Gmbh | Medical implant |
US20040002732A1 (en) | 2002-06-27 | 2004-01-01 | Clifford Teoh | Stretch-resistant vaso-occlusive assembly with multiple detaching points |
DE10233085B4 (en) * | 2002-07-19 | 2014-02-20 | Dendron Gmbh | Stent with guide wire |
AU2004215898A1 (en) * | 2003-02-26 | 2004-09-10 | Medivas, Llc | Bioactive stents and methods for use thereof |
DE102004003265A1 (en) * | 2004-01-21 | 2005-08-11 | Dendron Gmbh | Device for the implantation of electrically isolated occlusion coils |
US7323006B2 (en) * | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
DE602005025215D1 (en) | 2004-05-21 | 2011-01-20 | Micro Therapeutics Inc | METAL COILS EMBOSSED BY ORGANIC OR BIODEGRADABLE OR SYNTHETIC POLYMERS OR FIBERS FOR THE EMBOLIZATION OF A BODY HEIGHT |
WO2006032291A1 (en) * | 2004-09-22 | 2006-03-30 | Dendron Gmbh | Micro-spiral implantation device |
WO2006032289A1 (en) * | 2004-09-22 | 2006-03-30 | Dendron Gmbh | Medical implant |
DE102005019782A1 (en) * | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Device for implantation of occlusion coils with internal securing means |
JP5230602B2 (en) * | 2006-04-17 | 2013-07-10 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for mechanically positioning an endovascular implant |
US7689889B2 (en) * | 2006-08-24 | 2010-03-30 | Cisco Technology, Inc. | Content addressable memory entry coding for error detection and correction |
AU2008226694B8 (en) * | 2007-03-13 | 2013-06-20 | Covidien Lp | An implant including a coil and a stretch-resistant member |
KR20100015521A (en) * | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant, a mandrel, and a method of forming an implant |
EP2341843A1 (en) * | 2008-07-22 | 2011-07-13 | Micro Therapeutics, Inc. | Vascular remodeling device |
CN103263718B (en) * | 2008-08-19 | 2016-02-24 | 泰科保健集团有限合伙公司 | The microguide of separable end |
-
2005
- 2005-05-23 DE DE602005025215T patent/DE602005025215D1/en active Active
- 2005-05-23 AT AT05756033T patent/ATE490736T1/en not_active IP Right Cessation
- 2005-05-23 WO PCT/US2005/018087 patent/WO2005113035A2/en active Application Filing
- 2005-05-23 ES ES05756033T patent/ES2357243T3/en active Active
- 2005-05-23 CA CA2567331A patent/CA2567331C/en not_active Expired - Fee Related
- 2005-05-23 EP EP05756033A patent/EP1761178B1/en active Active
- 2005-05-23 ES ES10194009.6T patent/ES2440650T3/en active Active
- 2005-05-23 EP EP10194009.6A patent/EP2316355B1/en active Active
- 2005-05-23 JP JP2007527550A patent/JP4723584B2/en not_active Expired - Fee Related
- 2005-05-23 US US11/134,998 patent/US7896899B2/en active Active
-
2011
- 2011-01-20 US US13/010,671 patent/US8267955B2/en active Active
- 2011-02-23 JP JP2011037486A patent/JP5052682B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ATE490736T1 (en) | 2010-12-15 |
JP2008500148A (en) | 2008-01-10 |
US20110118777A1 (en) | 2011-05-19 |
JP4723584B2 (en) | 2011-07-13 |
WO2005113035A3 (en) | 2006-02-23 |
EP2316355B1 (en) | 2013-09-18 |
DE602005025215D1 (en) | 2011-01-20 |
ES2357243T3 (en) | 2011-04-20 |
EP1761178A2 (en) | 2007-03-14 |
JP5052682B2 (en) | 2012-10-17 |
JP2011136189A (en) | 2011-07-14 |
CA2567331C (en) | 2012-08-14 |
ES2440650T3 (en) | 2014-01-29 |
US20060036281A1 (en) | 2006-02-16 |
US7896899B2 (en) | 2011-03-01 |
US8267955B2 (en) | 2012-09-18 |
EP1761178B1 (en) | 2010-12-08 |
EP2316355A1 (en) | 2011-05-04 |
WO2005113035A2 (en) | 2005-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2567331A1 (en) | Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity | |
US8888806B2 (en) | Vasoocclusive coil with biplex windings to improve mechanical properties | |
JP2008500148A5 (en) | ||
JP2908363B2 (en) | Bioactive occlusion coil | |
US6544275B1 (en) | Vaso-occlusive coils with selectively flattened areas | |
JP2553309B2 (en) | Vascular occlusion device with tubular cover of woven or knitted fibers | |
EP1009294B1 (en) | Anatomically shaped vaso-occlusive device | |
AU669054B2 (en) | Vasoocclusion device containing radiopaque fibers | |
EP0747014B1 (en) | Multiple layered vaso-occlusive coils | |
EP1845867B1 (en) | Vaso-occlusive devices with attached polymer structures | |
EP1902678A2 (en) | Coaxial stretch-resistant vaso-occlusive device | |
JP2002502659A (en) | Vasoocclusive device with attached polymer fibers | |
JP2004511293A (en) | Non-overlapping spherical three-dimensional vaso-occlusive coil | |
EP2234546A1 (en) | Polymeric slotted tube coils |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20210525 |